While it possesses inherent analgesic and anti-inflammatory properties, making it a small molecule drug candidate itself (like HP 549), its main industrial role is as a key precursor in complex drug manufacturing. Isoxepac is mainly a crucial pharmaceutical intermediate, acting as a building block for synthesizing various Active Pharmaceutical Ingredients (APIs), notably anti-inflammatory and anti-allergic drugs like Olopatadine and potentially Loratadine.
Isoxepac
| API Name | Olopatadine |
|---|---|
| CAS No | 55453-87-7 |
| Molecular Formula | C16H12O4 |
| Molecular Weight | 268.26 g/mol |
| Synonyms | 2-(11-oxo-6H-benzo[c][1]benzoxepin-2-yl)acetic acid |
Zoho Contact Form - Pharma Intermediates
"*" indicates required fields
Frequently Asked Questions
While it possesses inherent analgesic and anti-inflammatory properties, making it a small molecule drug candidate itself (like HP 549), its main industrial role is as a key precursor in complex drug manufacturing. Isoxepac is mainly a crucial pharmaceutical intermediate, acting as a building block for synthesizing various Active Pharmaceutical Ingredients (APIs), notably anti-inflammatory and anti-allergic drugs like Olopatadine and potentially Loratadine.
The CAS number of Isoxepac is 55453-87-7.
The molecular formula of Isoxepac is C16H12O4.
The listed molecular weight of Isoxepac is 268.26 g/mol.
Isoxepac is listed as being used in connection with the following API: Olopatadine.
The listed synonym or IUPAC name for Isoxepac is 2-(11-oxo-6H-benzo[c][1]benzoxepin-2-yl)acetic acid.